Full programme

Session B.01: Virus and Host
Monday 1 May 2017 10:55 - 12:55

Chairs: Klaus Frueh & Martin Messerle

10:55 - 11:25
Invited Lecture: How, when, and why CMV acts like an RNA virus. Timothy Kowalik, Associate Professor University of Massachusetts Medical School, Worchester, United States of America
11:25 - 11:55
Invited Lecture: Fetal immunity or tolerance to CMV infection Arnaud Marchant, Director, Institute for Medical Immunology Université Libre de Bruxelles, Charleroi, Belgium
11:55 - 12:10
Role of cytoplasmic receptors NOD1 and NOD2 in CMV control Ravit Boger Johns Hopkins University School of Medicine, Baltimore, United States of America
12:10 - 12:25
The Human Cytomegalovirus tegument protein pp65 (pUL83) dampens interferon-type I production by inactivating the DNA sensor cGAS Valentina Dell'Oste Università degli Studi di Torino, Torino, Italy
12:25 - 12:40
Human cytomegalovirus genome replication is inhibited in mature Langerhans-type dendritic cells. Laura Hertel Children's Hospital Oakland Research Institute, Oakland, United States of America
12:40 - 12:55
CMV abrogates CD8 T-cell control by inhibiting apoptosis, not by inhibiting antigen presentation M. Zeeshan Chaudhry Helmholtz Center for Infection Studies, Braunschweig, Germany
CMV 2017: the 6th International congenital CMV conference/16th International CMV/betaherpesvirus workshop in 2017<